| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer
3 companies
Parsey Merdad is a Chief Medical Officer at GILEAD SCIENCES, INC. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $10.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 12,984 | $79.96 | $1,038,225.31 | -15.6% | -4.1% | -9.4% | |
| Dec 30, 2022 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 553 | $85.33 | $47,187.49 | -1.2% | -5.1% | -5.6% | |
| Aug 17, 2020 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 182 | $68.32 | $12,434.24 | -100% | - | - |